Sort
261,768 grants matching “gene therapy”
Circadian dysfunction and Epigenetic alterations in the pathogenesis of Alzheimer's Disease
$3,173,392Paula Alejandra Desplats · University Of California, San Diego · RF1 · FY2019 · AG
The Immunotherapy of Animal and Human Cancer
$3,172,648Steven A Rosenberg · Clinical Sciences · Z01 · FY2007 · CA
Project 2: Identification and Characterization of the Protein Interaction Network of EWS-FLI1
$3,170,580Miguel Nicolas Rivera · Dana-Farber Cancer Inst · U54 · FY2018 · CA
Environmental Signaling in Reproduction and Pregnancy
$3,170,137Francesco Demayo · National Institute Of Environmental Health Sciences · ZIA · FY2020 · ES
Development and optimization of a peptide inhibitor of influenza virus splicing for broad-spectrum antiviral therapy
$3,170,096Benjamin R. Tenoever · New York University School Of Medicine · R01 · FY2025 · AI
Novel Treatment Targets For Affective Disorders Through Cross-Species Investigation of Approach/Avoidance Decision Making
$3,167,713Diego A. Pizzagalli · Mclean Hospital · P50 · FY2022 · MH
FIH PHASE 1B/2A DOSE ESCALATION STUDY OF EG110A, A NONREPLICATIVE HSV 1-DERIVED GENE THERAPY, VIA INTRADETRUSOR INJECTIONS TO ADULT PARTICIPANTS WITH NDORELATED INCONTINENCE FOLLOWING SCI
$3,165,836Eg427 · · FY2025 · Defense Health Agency
Cerebral amyloid angiopathy, metabolic dysregulation, and the neurovascular unit - Resubmission - 1
$3,164,945Jorge A Ghiso · New York University School Of Medicine · RF1 · FY2020 · AG
Bronchiectasis and chronic airway infection
$3,164,321Kevin Fennelly · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Advancing Targeted Therapies for Cushing's Disease Using Pituitary Neuroendocrine Tumor Organoids
$3,162,826Yana Zavros · University Of Georgia · R01 · FY2025 · DK
A Treatment for Patients with Jansens Metaphyseal Chondrodysplasia (JMC)
$3,162,551Elizabeth Ottinger · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)
$3,162,086Joel Moss · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
Novel Treatment Targets For Affective Disorders Through Cross-Species Investigation of Approach/Avoidance Decision Making
$3,162,041Diego A. Pizzagalli · Mclean Hospital · P50 · FY2023 · MH
Integrated Multidisciplinary Strategies for Detection of Diabetic Retinopathies
$3,161,034Nader Sheibani · University Of Wisconsin-Madison · RC4 · FY2010 · EY
CCR Genomics Core
$3,160,426Elizabeth Conner · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
Southern California Primary Infection Program
$3,158,919University Of California San Diego · U01 · FY2003 · AI
Prostate Cancer Imaging
$3,157,187Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Biological and mechanical therapies enabled by cardiovascular interventional MRI
$3,155,649Robert J Lederman · Heart, Lung, And Blood Institute · Z01 · FY2007 · HL
BRAIN-ICU-2 Study: Bringing to Light the Risk Factors And Incidence of Neuropsychological Dysfunction (Dementia) in ICU Survivors, 2nd Study
$3,155,165E Wesley Ely · Vanderbilt University Medical Center · R01 · FY2024 · AG
Genetics of Early Onset Parkinson's Disease: Mitochondrial Drivers of PD Pathogenesis
$3,154,937Derek Narendra · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS
Novel Treatment Targets For Affective Disorders Through Cross-Species Investigation of Approach/Avoidance Decision Making
$3,151,881Diego A. Pizzagalli · Mclean Hospital · P50 · FY2024 · MH
IGF::OT::IGF DEVELOPMENT OF BIOPHARMACEUTICALS
$3,151,602Gautam Mitra · Leidos Biomedical Research, Inc. · N01 · FY2016 · CA
Role of Retrotransposon Activity in Neurodegeneration and Alzheimer's Disease
$3,148,529John M. Sedivy · Brown University · P01 · FY2025 · AG
Tuberculosis Imaging Program
$3,147,878Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIC · FY2024 · AI
Regional Oncology Research Center
$3,147,857William G. Nelson · Johns Hopkins University · P30 · FY2009 · CA